Type A - Verisk Analytics, Inc. (VRSK) 20261101 Stock Analysis
📅 Verisk Key Upcoming Events
- November 05, 2026 Q3 2026 Earnings Release (Confirmed)
- Description: Verisk has officially scheduled its third-quarter financial results and earnings conference call for November 5, 2026, before the U.S. market opens. Investors will focus on organic constant-currency revenue growth, underwriting and claims demand, adjusted EBITDA margins, cash generation, and whether full-year 2026 guidance remains achievable.
- Date Not Announced Potential AccuLynx Acquisition Closing
- Description: Following the Delaware Supreme Court’s October 23 ruling, Verisk remains obligated to pursue the proposed $2.35B acquisition of AccuLynx, subject to Federal Trade Commission review and customary closing conditions. Completion is uncertain, and no reliable closing date has been established.
🏢 Step 1: Verisk Company Overview & Business Model
Q1-A1. What is Verisk?
- Company Name (Ticker): Verisk Analytics, Inc. (VRSK)
- Sector: Industrials
- Exchange: NASDAQ
- Founded: 1971 (Insurance Services Office predecessor; Verisk Analytics incorporated May 23, 2008)
- Listing Date: October 07, 2009
- Fiscal Year End: December
- Headquarters: United States, Jersey City
- CEO: Lee Shavel
- Market Cap: $25.55B
- Shares Outstanding: 130.16M
- Current Stock Price: $196.30
- Annual Dividend Yield: 1.02%
- Ex-dividend Date: September 15, 2026 (ET, historical basis)
- As-of: November 01, 2026 (ET)
Q1-A2. How Does Verisk Make Money?
- Insurance Data Licensing and Analytics Subscriptions: Verisk generates recurring revenue by supplying proprietary insurance data, analytical models, specialized software, and decision-support tools to property and casualty insurers, reinsurers, brokers, and related industry participants.
- Underwriting Intelligence: Insurers pay for policy forms, rating rules, loss-cost information, catastrophe modeling, property characteristics, and risk-selection analytics. These products help customers determine which risks to insure and how to price them.
- Claims Technology and Analytics: Verisk supplies property repair estimation software, fraud detection, claims benchmarking, casualty analytics, and workflow solutions that help insurers assess and settle claims.
- Recurring Revenue Economics: Subscription and long-standing contractual relationships generate predictable revenue. Product expansion, annual pricing, additional data products, and deeper workflow integration support customer spending growth.
- Economic Value Proposition: Verisk helps insurers improve underwriting accuracy, control claims expenses, reduce fraud, and comply with industry requirements. Its economic value depends more on improving insurance decisions than on general enterprise technology spending.
Q1-A3. Verisk’s Revenue Segments & Core Income Sources
- FY2025 Revenue: $3.07B, an increase of 6.6% from FY2024.
- Underwriting & Rating: $2.18B, approximately 70.9% of consolidated revenue, growing 7.7% YoY.
- Claims: $892.80M, approximately 29.1% of consolidated revenue, growing 4.1% YoY.
- Underwriting & Rating Leadership: This is Verisk’s largest and faster-growing revenue category. Demand is supported by insurance pricing complexity, catastrophe exposure, regulatory reporting requirements, and the accumulation of proprietary risk information.
- Claims Business: Claims software benefits from insurers’ need to reduce settlement costs and improve operational efficiency. Property estimation, anti-fraud products, and casualty analytics are major offerings.
- Growth Mix: Underwriting contributed approximately 81% of FY2025 incremental revenue, indicating that the company’s growth remains concentrated in its larger business.
- Latest Quarterly Performance: Q2 2026 consolidated revenue reached $806M, up 4.3% YoY, while organic constant-currency growth was 5.8%. The difference reflects acquisition, divestiture, and currency effects.
Q1-A4. Who Are Verisk’s Competitors?
- Direct Competition:
- Moody’s and S&P Global: Compete in selected risk analytics, modeling, and specialized information markets, although their broader financial-information and ratings businesses differ materially from Verisk’s insurance focus.
- CoreLogic and Cotality-Related Property Data Offerings: Compete in property intelligence, valuation, and selected insurance-related data products.
- Guidewire Software: Provides insurance administration and workflow platforms that can overlap with or complement Verisk’s insurance technology ecosystem.
- CCC Intelligent Solutions: Competes in selected claims, automotive damage, and insurance workflow applications.
- Competitive Substitutes: Insurers can develop internal predictive models, use alternative specialist data providers, or integrate third-party AI tools into underwriting and claims processes.
- Industry Position: Verisk has a particularly strong competitive position in U.S. property and casualty insurance information, loss-cost analytics, and claims estimation workflows.
- Competitive Advantage: Long historical datasets, insurer contributions, regulatory familiarity, and integration into daily decision-making create substantial switching costs.
- Competitive Limitation: Verisk does not possess exclusive control over every insurance dataset or workflow. Modern software platforms and increasingly accessible predictive AI models can challenge specific premium-priced products.
Q1-A5. Verisk Key Events: Past 12 Months
- December 26, 2025 Termination of the Proposed AccuLynx Acquisition
- Description: Verisk attempted to terminate its previously announced agreement to acquire AccuLynx. The counterparty disputed the termination, creating litigation over the $2.35B transaction.
- April 29, 2026 Q1 2026 Financial Results
- Description: Revenue increased 3.9% to $783M, while adjusted EBITDA increased 5.0% to $438M. Adjusted diluted EPS increased 5.2% to $1.82, demonstrating continued profitability despite moderate revenue growth.
- July 29, 2026 Q2 2026 Earnings Release
- Description: Revenue increased 4.3% to $806M and adjusted EBITDA increased 4.2% to $464M. GAAP diluted EPS declined 3.3% to $1.75, while adjusted EPS rose 5.3% to $1.98. Quarterly FCF increased 57.9% to $298M.
- July 29, 2026 Acquisition of McKenzie Intelligence Services
- Description: Verisk acquired a provider of geospatial intelligence and catastrophe-response analytics, expanding its capabilities in damage assessment and real-time event intelligence.
- August 07, 2026 Delaware Chancery Court Ruling on AccuLynx
- Description: The court determined that Verisk could not validly terminate the acquisition agreement under the circumstances presented. The ruling created a potential obligation to continue pursuing the transaction.
- September 03, 2026 Launch of Data Center Exposure Analytics
- Description: Verisk introduced insurance-focused analytics addressing concentrated data center exposure, demonstrating its ability to monetize emerging property-risk categories.
- October 23, 2026 Delaware Supreme Court Affirms AccuLynx Ruling
- Description: The Supreme Court affirmed the lower court’s judgment. Verisk stated that the acquisition remains subject to customary closing conditions and FTC review, with no guarantee of completion.
- October 28, 2026 Expansion of Insurance Intelligence Across AI Platforms
- Description: Verisk announced initiatives bringing proprietary insurance intelligence to Amazon and Microsoft AI platforms while expanding offerings within Claude. The commercial significance will depend on adoption, monetization, and preservation of proprietary data economics.
Q1-A6. Step 1 Key Takeaways
- Step 1 Summary: Verisk operates a highly specialized, recurring-revenue insurance data and analytics franchise with significant competitive advantages. Recent operating performance remains resilient, while the unresolved AccuLynx acquisition introduces a material capital-allocation and regulatory uncertainty.
🏰 Step 2: Verisk’s Economic Moat, Growth & Capital Allocation
Q2-A1. Does Verisk Have a Durable Economic Moat?
- Proprietary Data Advantage: Verisk’s extensive historical insurance information, loss-cost databases, catastrophe models, and specialized datasets are difficult to replicate quickly.
- Switching Costs: Insurance underwriting and claims systems are embedded in complex operating procedures. Replacing established analytical tools can require retraining, integration work, model validation, and changes to compliance processes.
- Industry Network Effects: Historical insurer data contributions and broad product adoption improve the breadth and usefulness of certain databases, although these effects are not equally strong across every product.
- Pricing Power: FY2025 underwriting revenue increased 7.7%, supported partly by pricing improvements and expansion of specialized analytical content.
- Profitability Defense: TTM operating margin of approximately 44.9% and ROIC of approximately 31.7% indicate substantial economic profitability.
- Moat Conclusion: Verisk possesses a durable combination of proprietary information, specialized expertise, customer integration, and pricing power. Its strongest advantage comes from insurance-specific datasets rather than generic software functionality.
Q2-A2. Is Verisk’s Growth Sustainable?
- Industry Structure and Outlook: Property and casualty insurance analytics is a mature but expanding market. Growth is supported by climate-related loss complexity, property risk modeling, claims automation, evolving insurance regulation, and increasing demand for granular underwriting data.
- Growth Sustainability: FY2025 organic growth excluding acquisitions and dispositions was approximately 6.9%, while Q2 2026 organic constant-currency growth reached 5.8%. Mid-single-digit organic growth appears more defensible than a sustained double-digit revenue expansion assumption.
- Downside Scenarios:
- 1 Insurer Budget Pressure: Weak insurance profitability or consolidation could lead insurers to negotiate contracts more aggressively and postpone additional analytics purchases.
- 2 AI-Driven Competition: Alternative AI models and cheaper data-processing tools could reduce the differentiation of selected Verisk products.
- 3 Reduced Insurance Activity: Slower policy growth, lower transaction volumes, or changing insurance distribution structures could limit demand for selected underwriting and claims products.
Q2-A3. How Does Verisk Allocate Capital & Return Cash?
- Share Repurchases: Verisk funded approximately $1.90B of aggregate repurchases during the first half of 2026, including transactions not yet settled, and received initial delivery of approximately 8.50M shares.
- Share Count Reduction: Shares outstanding decreased approximately 3.58% YoY, directly supporting per-share earnings and cash-flow growth.
- Dividend Policy: The indicated annual dividend is $2.00 per share, representing approximately 1.02% of the current stock price.
- Reinvestment: Acquisitions and internal investment target catastrophe analytics, underwriting data, claims technology, and adjacent insurance workflows.
- Capital Allocation Risk: The proposed $2.35B AccuLynx transaction could consume substantial financial flexibility if completed. Its commercial returns, integration costs, and financing requirements must be assessed separately from existing operations.
- Capital Allocation Assessment: Repurchases and operating reinvestment have created shareholder value, but the uncertain acquisition outcome prevents an unqualified assessment of management’s capital discipline.
Q2-A4. Step 2 Key Takeaways
- Scoring Rationale:
- Economic Moat (9/10): Proprietary insurance data, deeply integrated workflows, and high operating profitability support a strong moat, although selected software functions face emerging competition.
- Growth Sustainability (7/8): Recurring demand and measurable organic expansion are durable, but insurance-sector maturity limits the likely long-term growth rate.
- Capital Allocation (6/7): Significant repurchases and consistent dividends support shareholders, while the AccuLynx transaction adds uncertainty.
- 📊 Step 2 Score: 22/25 pts (Economic Moat 9/10 + Growth Sustainability 7/8 + Capital Allocation 6/7)
- Step 2 Summary: Verisk combines a strong data-based moat with recurring organic growth and shareholder distributions. The primary constraint is uncertainty around acquisition-related capital commitments.
💰 Step 3: Is Verisk Profitable? Financial Health Analysis
Q3-A1. Verisk’s Growth & Profitability Trends
- Revenue Expanded Steadily: FY2024 revenue was $2.88B, increasing to $3.07B in FY2025 and approximately $3.14B for the twelve months ended June 2026. The respective FY2025 and latest TTM growth rates were 6.6% and 5.0%.
- Operating Profitability Remained Strong: Operating income increased from $1.27B in FY2024 to $1.38B in FY2025 and $1.41B on the latest TTM basis. Operating margin improved from approximately 44.2% in FY2024 to 44.8% in FY2025 and 44.9% TTM.
- GAAP Earnings Were Less Consistent: Net income declined from $958.20M in FY2024 to $908.30M in FY2025 and $885.50M TTM. Diluted EPS moved from $6.71 to $6.48 and then approximately $6.50, reflecting the combined effects of earnings fluctuations and share repurchases.
- Free Cash Flow Improved Materially: FCF increased from $920.10M in FY2024 to $1.19B in FY2025 and $1.24B TTM. FCF margin expanded from approximately 31.9% to 38.8% and 39.4% over these periods.
- Operating Leverage Assessment: Operating margins have expanded modestly, while FCF conversion improved significantly. The cash-flow improvement is stronger than the underlying revenue acceleration and includes working-capital timing effects.
Q3-A2. How Profitable Is Verisk? (Margins & ROIC)
- Operating Margin: 44.93% TTM, reflecting strong recurring information economics and substantial operating scale.
- Net Profit Margin: 28.24% TTM, demonstrating attractive profitability after financing costs and taxes.
- ROIC: Approximately 31.68%, substantially exceeding an estimated 7.32% WACC.
- Economic Value Creation: The approximate ROIC-WACC spread is +24.36 percentage points, indicating significant value creation on the measured invested-capital base.
- ROA: Approximately 18.96%, supporting strong asset productivity.
- Comparative Position: Verisk’s estimated ROIC is broadly comparable with Moody’s and substantially higher than the corresponding measures for S&P Global and Equifax. Business mix and invested-capital accounting affect these comparisons.
- Assessment: The magnitude of the return spread supports the existence of a durable economic moat, although acquisitions and changes in goodwill can distort the accounting capital base.
Q3-A3. What Drives Verisk’s Returns? (ROIC Breakdown)
- Selected Efficiency Indicators: Recurring Revenue Growth, Operating Margin, and Cash Conversion — these metrics best capture Verisk’s specialized insurance information economics.
- Recurring Revenue Growth: Organic constant-currency revenue growth of 5.8% in Q2 2026 indicates continuing demand from existing insurance workflows and expanded analytical offerings. A standardized company-wide NRR figure was not established.
- Operating Margin: The TTM margin of 44.93% illustrates how reusable analytical content and established customer integrations support profitability.
- Cash Conversion: TTM FCF of $1.24B represented approximately 39.4% of revenue, indicating that operating earnings translate efficiently into discretionary cash generation.
- Operational Driver: Verisk can monetize existing proprietary datasets across multiple insurers and use cases without proportionate increases in physical production costs.
- Return Driver Conclusion: Pricing power, contract renewal economics, and efficient cash conversion underpin elevated ROIC, although future acquisitions may increase invested capital before generating corresponding returns.
Q3-A4. Are Verisk’s Earnings High Quality?
- Operating Cash Flow: Approximately $1.50B TTM, compared with $885.50M of net income.
- OCF/Net Income: Approximately 1.70x, indicating that reported earnings are strongly supported by operating cash generation.
- FCF/Net Income: Approximately 1.40x, reinforcing cash conversion after capital spending.
- Working-Capital Effects: Receivable collection, deferred revenue movements, and the timing of vendor and tax payments influence individual quarters.
- Earnings Quality Conclusion: Cash generation exceeds accounting earnings by a substantial margin. Nevertheless, acquisition-related adjustments and noncash amortization require careful reconciliation when comparing GAAP and adjusted results.
Q3-A5. Is Verisk’s Balance Sheet Healthy? (Debt & Leverage)
- Cash and Liquidity: Approximately $552.20M in cash and short-term investments as of June 30, 2026.
- Total Debt: Approximately $4.62B.
- Net Debt: Approximately $4.06B, following substantial shareholder repurchases and financing activity.
- Net Debt/EBITDA: Approximately 2.68x using the standardized trailing EBITDA denominator.
- Interest Coverage: Approximately 7.22x, indicating adequate coverage of financing expenses by operating earnings.
- Current Ratio: Approximately 1.00x, consistent with a business generating recurring cash flow but maintaining limited excess working capital.
- Acquisition Financing Exposure: The potential $2.35B AccuLynx payment is large relative to available cash and annual FCF. Completion could increase borrowings or restrict repurchase capacity.
- Balance Sheet Conclusion: Existing debt remains manageable given operating cash generation, but the company has less financial flexibility than an unlevered analytics business.
Q3-A6. Step 3 Key Takeaways
- Scoring Rationale:
- Profitability·Capital Efficiency (9/10): Strong operating margins and a substantial ROIC-WACC spread demonstrate high economic profitability.
- Cash Flow·Profit Quality (8/8): Operating cash flow and free cash flow materially exceed reported net income, with improving multiyear conversion.
- Financial Soundness·Debt Management (4/7): Debt service is manageable, but meaningful leverage and potential acquisition financing constrain financial flexibility.
- 📊 Step 3 Score: 21/25 pts (Profitability·Capital Efficiency 9/10 + Cash Flow·Profit Quality 8/8 + Financial Soundness·Debt Management 4/7)
- Step 3 Summary: Verisk’s exceptional cash conversion and strong capital efficiency support its financial profile. Leverage and possible acquisition funding remain the principal balance-sheet concerns.
🔎 Step 4: Verisk Forensic Accounting & Dilution Review
Q4-A1. Does Verisk Have Accounting Red Flags?
- Revenue recognition: not found
- Evidence: The recurring subscription and data-licensing structure supports predictable revenue recognition. The reviewed disclosures did not establish a material revenue recognition irregularity.
- Cost capitalization: not found
- Evidence: Capital spending and amortization are material, but the available cash-flow and profitability trends do not establish an inappropriate capitalization practice.
- Sharp increase in accounts receivable and inventory: not found
- Evidence: Accounts receivable decreased from approximately $422.20M at FY2025 to $400.00M in June 2026. Physical inventory is not a significant operating driver.
- Non-recurring adjustment (normalization): discovered
- Evidence: Verisk reports adjusted EBITDA and adjusted EPS alongside GAAP results. Acquisition-related expenses, intangible amortization, and other adjustments require monitoring because adjusted earnings can differ materially from shareholder-accounting earnings.
Q4-A2. Is Verisk Overspending? (Capex & Capital Cycle)
- ➖ Not applicable: Verisk is primarily a data, analytics, and specialized software provider rather than a capital-intensive manufacturer. Its main investment risks involve software development, data acquisition, and business acquisitions rather than industrywide physical production overcapacity.
Q4-A3. How Sound Is Verisk’s Cash Flow?
- Strong Operating Cash Generation: TTM operating cash flow reached approximately $1.50B, compared with net income of $885.50M.
- Capital Spending: TTM capital expenditures were approximately $266.70M, representing about 8.5% of revenue.
- Positive Free Cash Flow: FCF reached approximately $1.24B, materially exceeding accounting earnings.
- Cash Allocation Warning: Substantial repurchases and potential acquisition funding can exceed internally generated annual FCF in individual periods, increasing dependence on borrowing or balance-sheet cash.
- Assessment: Core operations are not dependent on external financing for survival. Financing risk relates primarily to discretionary capital allocation rather than operating cash burn.
Q4-A4. Is Verisk Diluting Shareholders?
- ⏪ Confirmed (Past) Dilution: Shares outstanding declined approximately 3.58% YoY to 130.16M, indicating net share retirement rather than dilution. Large repurchases have more than offset equity compensation and issuance.
- ⏩ Potential (Future) Dilution & Overhang: TTM stock-based compensation was approximately $57.60M, modest relative to operating cash flow. Future share issuance remains possible through compensation arrangements, but no material equity-financing overhang was established. The larger potential funding issue is acquisition-related borrowing.
Q4-A5. Data Integrity Check
- Period: FY2025, Q2 2026, and TTM ending June 2026 figures are separately identified ➡ (Pass)
- Definition: GAAP EPS and net income are distinguished from adjusted EPS and EBITDA; FCF uses operating cash flow less capital expenditures ➡ (Pass)
- Number of Shares: Current outstanding shares are distinguished from historical diluted weighted-average share counts ➡ (Pass)
- Unit: Financial amounts are expressed in USD and consistently scaled in millions or billions ➡ (Pass)
- Single Value Confirmation: Reported quarterly results and standardized trailing calculations are aligned by period and definition; differences between GAAP and non-GAAP figures are preserved rather than combined ➡ (Pass)
Q4-A6. Step 4 Key Takeaways
- Scoring Rationale:
- Accounting anomalies·distortion signals (6/8): No established major accounting irregularity, although adjusted earnings and acquisition accounting require scrutiny.
- Cash flow warning signals (7/7): Strong, positive, and growing operating cash generation supports earnings quality.
- Dilution factors (4/5): Net share retirement is substantial, with modest stock-based compensation relative to cash flow.
- 📊 Step 4 Score: 17/20 pts (Accounting anomalies·distortion signals 6/8 + Cash flow warning signals 7/7 + Dilution factors 4/5)
- Step 4 Summary: Verisk’s cash generation and shrinking share count support a strong forensic profile. Adjusted accounting measures and acquisition-related commitments warrant continued monitoring.
👔 Step 5: Verisk Management & Shareholder Alignment
Q5-A1. Can You Trust Verisk’s Management? (Guidance Track Record)
- Guidance Discipline: After Q2 2026, Verisk maintained its FY2026 revenue guidance of $3.19B-$3.24B and adjusted diluted EPS guidance of $7.45-$7.75.
- Operational Delivery: Q2 organic constant-currency growth of 5.8% and adjusted EBITDA growth of 4.2% support continued operational execution, although reported GAAP earnings declined.
- Capital Allocation Credibility: Substantial share repurchases demonstrate management’s commitment to per-share value creation.
- Execution Concern: The AccuLynx dispute and subsequent court rulings represent an important governance and transaction-execution concern. A legally contested acquisition can impose financing and strategic costs that were not part of an uncomplicated capital-allocation plan.
- Assessment: Operational execution has been credible, but acquisition decision-making deserves greater scrutiny.
Q5-A2. What Are Verisk Insiders Doing?
- CEO Transactions: CEO Lee Shavel sold 3,535 shares on October 1, 2026, at approximately $170.70 per share. A corresponding 3,535-share acquisition through option exercise was reported at $104.00, with the transactions flagged under a Rule 10b5-1 plan.
- CFO Transactions: CFO Elizabeth Mann sold 400 shares on October 15, 2026, at approximately $184.85 per share. Similar 400-share planned transactions were recorded in September and August.
- Additional Executive Sale: Chief Legal Officer Kathy Card Beckles sold 2,020 shares on July 31, 2026, at approximately $195.49 per share.
- Net Trading Direction: The retrieved recent transactions were predominantly sales, including planned and option-related activity. A complete independently reconciled trailing-12-month net share-flow total was not established.
- Management Sentiment: Planned executive selling is not strong standalone evidence of deteriorating confidence. No verified broad cluster of discretionary executive purchases was identified in the reviewed recent activity.
Q5-A3. Is Verisk’s Management Aligned With Shareholders?
- Shareholder Structure: Verisk trades through a single current common-stock structure without a presently identified dual-class voting arrangement.
- Executive Incentives: Equity-linked compensation creates financial exposure to shareholder outcomes, although specific performance hurdles require monitoring for alignment with organic growth, ROIC, and per-share FCF.
- Buyback Alignment: The declining share count supports per-share economics.
- Governance Concern: The AccuLynx transaction raises questions about acquisition discipline, contractual risk, and the possible divergence between management’s strategic preferences and shareholder capital efficiency.
- Conclusion: Shareholder alignment is generally constructive, but acquisition governance prevents a top-tier assessment.
Q5-A4. Step 5 Key Takeaways
- Scoring Rationale:
- Management Trust (3/5): Operating delivery has been credible, but the unresolved acquisition dispute weakens transaction-execution confidence.
- Insider Trends (3/5): Recent insider selling is largely consistent with planned transactions, while discretionary buying evidence is limited.
- Governance·Compensation System (5/5): A conventional common-stock structure, shareholder distributions, and equity-linked incentives provide substantial alignment despite specific acquisition concerns.
- 📊 Step 5 Score: 11/15 pts (Management Trust 3/5 + Insider Trends 3/5 + Governance·Compensation System 5/5)
- Step 5 Summary: Management has demonstrated solid operating discipline and meaningful shareholder returns. Acquisition governance and the absence of strong discretionary insider buying temper the assessment.
⛵ Step 6: Verisk Market Flow & Sentiment
Q6-A1. Analyst Consensus vs Verisk Guidance
- FY2026 Revenue Guidance: $3.19B-$3.24B, midpoint $3.215B.
- FY2026 Adjusted EPS Guidance: $7.45-$7.75, midpoint $7.60.
- Compiled FY2026 EPS Estimate: Approximately $7.71, or about 1.4% above the company guidance midpoint. This comparison is directionally useful only to the extent the estimate uses a compatible adjusted earnings basis.
- Revenue Expectations: Compiled FY2026 revenue expectations are approximately $3.20B, broadly consistent with the company’s outlook.
- Analyst Sentiment: The analyst consensus remains positive, with a compiled average 12-month target near $226.47. However, individual analysts have revised targets in response to valuation, operating expectations, and acquisition uncertainty.
- Expectation Gap: The relatively modest gap between management guidance and compiled expectations reduces the risk of an extreme guidance-versus-consensus mismatch, although the upcoming quarterly announcement could change that balance.
Q6-A2. What Is Verisk’s Short Interest?
- Institutional Ownership: Reported institutional ownership is approximately 100.78% of shares outstanding, a figure influenced by institutional reporting conventions and possible overlapping holdings rather than literal ownership of more than all economic shares.
- Short Interest: Approximately 4.42M shares.
- Short Interest as Percentage of Float: Approximately 3.40%.
- Days to Cover: Approximately 3.45 trading days.
- Short Interest Trend: Short interest increased from approximately 4.18M shares in the preceding reported period to 4.42M.
- Market Interpretation: Short interest is elevated enough to show skepticism but not high enough to indicate an unusually strong short-squeeze setup. Institutional participation remains substantial.
Q6-A3. Step 6 Key Takeaways
- Scoring Rationale:
- Consensus vs Guidance (2/3): FY2026 revenue expectations broadly align with guidance, while EPS expectations are modestly higher.
- Supply·Short Interest (1/2): Institutional ownership is substantial, but short interest has increased and remains meaningful.
- 📊 Step 6 Score: 3/5 pts (Consensus vs Guidance 2/3 + Supply·Short Interest 1/2)
- Step 6 Summary: Market expectations remain constructive but not uniformly bullish. Moderate short interest and acquisition uncertainty create room for volatility around upcoming financial results.
🚀 Step 7: Verisk Catalysts & Price Triggers
Q7-A1. What Could Move Verisk Stock? (Top 3 Catalysts)
- 1 Q3 2026 Earnings and Full-Year Guidance Confirmation
- Timing: November 05, 2026
- Success Conditions: Organic constant-currency revenue growth remains near the recent mid-single-digit rate, adjusted EBITDA margins remain resilient, and full-year guidance is maintained or improved.
- Failure Risk: Organic growth slows materially or management reduces revenue, adjusted EPS, or cash-flow expectations.
- 2 Expansion of Insurance Analytics Through AI Integrations
- Timing: Next 6-12 months
- Success Conditions: Verisk demonstrates measurable commercial adoption of its insurance intelligence across integrated AI platforms without sacrificing data pricing power or customer relationships.
- Failure Risk: AI integrations generate limited incremental revenue or make the underlying analytics easier for customers to substitute.
- 3 Resolution of AccuLynx Acquisition Uncertainty
- Timing: Conditional on FTC review and remaining transaction requirements; no confirmed completion date.
- Success Conditions: A resolution establishes funding requirements, integration economics, and the transaction’s strategic value without materially impairing financial flexibility.
- Failure Risk: Prolonged uncertainty, unfavorable financing conditions, or weak acquisition returns reduce future free cash flow available to shareholders.
Q7-A2. Verisk’s Earnings Revision Trend
- FY2026 Expectations: Compiled EPS expectations of approximately $7.71 remain within the company’s adjusted EPS guidance range.
- Growth Expectations: The latest compiled FY2026 EPS estimate implies mid- to high-single-digit adjusted earnings growth, but it is not directly comparable with GAAP EPS growth.
- Revision Assessment: Recent analyst target changes suggest mixed confidence in the valuation and risk outlook. A reliable numerical 90-day EPS estimate revision series was not established.
- Investment Implication: The November earnings release is the clearest near-term opportunity for either positive estimate revisions or negative reassessment.
Q7-A3. Step 7 Key Takeaways
- Scoring Rationale:
- Catalyst (6/7): The near-term earnings release, AI product distribution, and acquisition resolution provide several material catalysts with identifiable success conditions.
- EPS Trend (2/3): Adjusted earnings expectations remain constructive, but a sustained upward revision trend is not established.
- 📊 Step 7 Score: 8/10 pts (Catalyst 6/7 + EPS Trend 2/3)
- Step 7 Summary: Verisk has meaningful earnings and strategic catalysts, although acquisition uncertainty and unclear revision momentum limit confidence in near-term rerating.
⚖️ Step 8: Is Verisk Fairly Valued? Valuation Analysis
Q8-A1. Verisk’s Key Valuation Multiples
- PE Ratio: 30.21x (fairly valued) — Elevated versus the broader market, but supported by recurring revenue, high margins, and strong capital returns.
- PS Ratio: 8.15x (fairly valued) — High relative to ordinary service companies but supported by the company’s exceptional profitability.
- PB Ratio: N/A (not applicable) — Negative book equity makes conventional P/B interpretation economically unreliable.
- P/TBV Ratio: N/A (not applicable) — Negative tangible book equity makes the multiple unsuitable.
- P/FCF Ratio: 20.66x (undervalued) — Approximately 4.84% trailing FCF yield provides a more attractive valuation signal than earnings multiples alone.
- P/OCF Ratio: 17.00x (undervalued) — Strong operating cash generation supports the equity valuation.
- EV/Sales Ratio: 9.44x (fairly valued) — Reflects high operating profitability and durable recurring revenue.
- EV/EBITDA Ratio: 19.54x (fairly valued) — A meaningful premium to conventional services businesses, partly justified by specialized data economics.
- EV/EBIT Ratio: 21.02x (fairly valued) — High but supported by profitability and comparatively limited physical capital intensity.
- EV/FCF Ratio: 23.95x (fairly valued) — Net debt reduces the apparent attractiveness of the equity FCF multiple.
- Forward PE: 24.04x (fairly valued) — Moderate relative to premium analytics franchises, assuming expected earnings materialize.
- PEG Ratio: 2.04x (fairly valued) — Indicates that the valuation still embeds a meaningful quality premium relative to projected growth.
- Scoring Rationale: Cash-flow multiples are more favorable than the trailing earnings multiple, and the business produces substantial returns on invested capital. The current price offers some fundamental value but not an unusually large absolute margin of safety.
- 📌 (1) Axis Q8-A1 Score: +2
Q8-A2. Verisk vs Peers: Valuation Comparison
- Multiple selection based on peer comparison: Forward P/E is selected because Verisk, Moody’s, S&P Global, and Equifax are established, profitable information and analytics providers. Their customer markets and growth economics differ, so the comparison is an imperfect but useful benchmark.
- Calculation of peer-to-peer deviation rate: +0.46% versus the arithmetic peer average.
- 🧮 Calculation Formula: Verisk Forward P/E 24.04x; peer Forward P/E values: Moody’s 27.41x, S&P Global 23.98x, Equifax 20.41x; peer mean = (27.41 + 23.98 + 20.41) / 3 = 23.93x; deviation = (24.04 - 23.93) / 23.93 × 100 = +0.46%.
- Scoring Rationale: Verisk trades close to the selected peer average. Its superior capital efficiency supports a premium to some peers, while its narrower industry concentration and acquisition uncertainty justify some discount to the strongest diversified franchises.
- 📌 (2) Axis Q8-A2 Score: 0
Q8-A3. Is Verisk Cheap or Expensive vs Its History?
- Comparison Indicators:
- Selected Metric: Trailing P/FCF, using comparable fiscal-year-end observations.
- Historical Coverage: Five consecutive annual observations, FY2021-FY2025, plus the current October 2026 valuation.
- FY2021: 41.55x
- FY2022: 35.18x
- FY2023: 41.69x
- FY2024: 42.27x
- FY2025: 26.16x
- Observed Minimum: 26.16x
- Observed Maximum: 42.27x
- Current: 20.66x
- Range Position: (20.66 - 26.16) / (42.27 - 26.16) × 100 = -34.1%.
- Scoring Rationale: The current P/FCF multiple is below every annual endpoint in the five-year sample, placing it beneath the observed historical range. This indicates substantial relative de-rating, although historical premiums reflected different interest rates, growth expectations, and acquisition circumstances. The sample is annual rather than quarterly and should not be interpreted as a complete trading-history percentile.
- 📌 (3) Axis Q8-A3 Score: +4
Q8-A4. What Growth Is Priced Into Verisk? (Reverse DCF)
- Implied Growth Rate: 7.5%
- 1 Methodology: A simplified ten-year discounted equity cash-flow model solves for the constant annual growth rate required to justify the approximately $25.55B current equity market capitalization.
- 2 Core assumptions: Starting normalized levered FCF of approximately $1.06B, a 9.0% cost of equity, a 3.0% terminal growth rate, a ten-year explicit period, and no separate incremental value for acquisitions. Levered FCF is used to match equity value rather than enterprise value.
- Achievable Growth Rate: 7.0%
- Basis: An analytical assumption reflecting mid-single-digit organic revenue growth, modest margin expansion, and some per-share benefit from continuing repurchases, offset by financing costs and reinvestment needs. This is a conditional forecast rather than company guidance.
- Growth gap and difficulty assessment:
- 🧮 Formula: Achievable Growth Rate 7.0% - Implied Growth Rate 7.5% = -0.5%p
- Scoring Rationale: The assumed achievable growth rate is close to the growth required by the current equity valuation. The result is particularly sensitive to terminal growth, discount rates, future acquisition financing, and whether current cash conversion is sustainable. Expectations appear broadly achievable but do not establish a large intrinsic discount.
- 📌 (4) Axis Q8-A4 Score: 0
Q8-A4-1. What Growth Hurdle Does the Market Demand From Verisk? (Reverse DCF Alternative)
- Scoring Rationale: Not applicable — the available trailing levered cash-flow base supports a simplified equity-based reverse DCF with explicit growth, discount-rate, and terminal assumptions.
- 📌 (4) Axis Q8-A4-1 Score: ➖
Q8-A5. Verisk’s Hidden Asset & Stake Valuation
- Scoring Rationale: Not applicable — Verisk is principally an operating data and analytics company, and no separately valued investment holdings or independently monetizable assets meeting the required materiality threshold have been established.
- 📌 (5) Axis Q8-A5 Score: ➖
Q8-A6. Final Valuation Adjustment
- Scoring Rationale: No additional valuation adjustment is assigned. The company’s proprietary data franchise, exceptional profitability, and acquisition-related capital requirements are already incorporated into its operating forecasts, discount-rate considerations, and valuation comparisons.
- 📌 (6) Axis Q8-A6 Score: 0
Q8-A7. Valuation Adjustment Score Calculation
- Calculation Process:
- (1) Axis (Key Valuation Indicators): +2 pts (Undervalued)
- (2) Axis (Peer-to-peer deviation rate): 0 pts (+0.46% vs peers)
- (3) Axis (Historical Band Position): +4 pts (observed-range position p = -34.1%; very undervalued)
- (4) Axis (Justification for Growth): 0 pts (Achievable growth of 7.0% versus implied growth of 7.5%)
- (5) Axis (Held assets·Share Valuation): 0 pts (Not applicable)
- (6) Axis (Final adjustment): 0 pts (No additional independent valuation factor)
- 📊 Valuation Adjustment Score: A1 (+2) + A2 (0) + A3 (+4) + A4 (0) + A5 (0) + A6 (0) = +6 pts
- Commentary: Verisk’s historical cash-flow valuation has compressed substantially, creating relative attractiveness. However, current peer multiples and the reverse DCF indicate that the stock is not priced for an unusually pessimistic operating scenario.
- Step 8 Summary: Valuation is more attractive than its recent historical norms, but the investment case still depends on sustained cash-flow growth and disciplined acquisition financing.
💀 Step 9: What Are the Risks of Verisk? Fatal Risks & Pre-Mortem
Q9-A1. What Are the Biggest Risks to Verisk?
- 1 AccuLynx acquisition financing and execution risk:
- Cause: The Delaware Supreme Court affirmed a judgment requiring Verisk to continue pursuing the previously disputed $2.35B acquisition, subject to regulatory approval and remaining conditions.
- Impact: If completed, the transaction could substantially increase financing requirements, reduce repurchase flexibility, and create integration risks. The commitment is material relative to annual FCF and cash reserves.
- Mitigation/Monitoring Indicators: FTC review developments, financing arrangements, transaction closing conditions, net debt/EBITDA, and subsequent management guidance.
- 2 Competitive disruption in insurance analytics:
- Cause: New AI tools, insurer-developed analytical systems, and alternative industry data providers could challenge selected Verisk offerings.
- Impact: Weaker pricing, customer retention, or product differentiation could reduce organic growth and operating margins.
- Mitigation/Monitoring Indicators: Organic constant-currency growth, renewal performance, product adoption, pricing trends, and operating margins.
- 3 Insurance industry concentration:
- Cause: Verisk derives substantially all reported revenue from insurance-related data and technology customers.
- Impact: Industry consolidation, insurer budget reductions, or changing underwriting practices could produce correlated demand weakness across products.
- Mitigation/Monitoring Indicators: Underwriting revenue growth, claims revenue growth, insurance customer spending, and policy-market activity.
Q9-A2. How Sensitive Is Verisk to the Economy?
- 1 Higher Interest Rates (Negative Impact ⬇): Higher refinancing costs can increase interest expense and reduce the cash available for repurchases or acquisitions.
- 2 Greater Insurance Regulatory Complexity (Positive Impact ⬆): More complex insurance reporting and risk-pricing requirements can increase demand for Verisk’s specialized data and compliance-related tools, assuming insurers retain sufficient budgets.
- 3 Stricter Acquisition Antitrust Review (Negative Impact ⬇): Extended regulatory review can delay or complicate acquisition completion, prolonging financing and strategic uncertainty.
Q9-A3. Verisk Pre-Mortem: What Could Go Wrong?
- 1 The AccuLynx transaction creates a prolonged capital-allocation setback: Acquisition financing, integration expenses, and disappointing returns restrict shareholder distributions while creating pressure on leverage.
- Early Warning Signal: A material rise in expected net debt, a reduction in repurchase plans, or a downward revision to post-acquisition cash-flow guidance.
- 2 Proprietary insurance data loses part of its pricing advantage: AI-based alternatives and insurer-developed systems become credible substitutes, limiting renewals and pricing growth.
- Early Warning Signal: Sustained organic revenue growth below recent trends alongside deterioration in operating margins.
- 3 Insurance customer spending weakens across major product categories: Industry consolidation and pressure on insurer profitability reduce demand for optional analytical products.
- Early Warning Signal: Simultaneous slowing of underwriting and claims revenue, accompanied by weaker forward guidance.
Q9-A4. Risk Adjustment Score
- Reason for Scoring: Verisk faces a material, ongoing transaction-related financial exposure. The proposed $2.35B AccuLynx acquisition is substantial relative to approximately $552M in cash and $1.24B in annualized trailing FCF, and the October 23 court ruling materially constrains management’s ability to abandon the agreement. Regulatory approval remains uncertain, so the financing outcome is conditional rather than an established expense. Existing net debt of approximately $4.06B increases the importance of this exposure. Strong operating cash generation and interest coverage provide meaningful mitigants.
- 📊 Risk Adjustment Score: -7 pts
- Step 9 Summary: The primary downside exposure is transaction-related capital commitment rather than operating insolvency. Verisk’s strong core business reduces financial distress risk, but the acquisition outcome could materially change shareholder cash-flow economics.
🎯 Step 10: Verisk Final Verdict: Score & Rating
Q10-A1. Investment Score & Rating
- Investment Score Calculation Formula:
- Step breakdown: S2 (22) + S3 (21) + S4 (17) + S5 (11) + S6 (3) + S7 (8) = 82 pts
- Steps 2-7 Sum (82 pts) + Valuation Adjustment (+6 pts) + Risk Adjustment (-7 pts) = Investment Score 81 pts
- Investment Score & Rating: 81 pts (A Rating ⭐⭐⭐⭐)
- Commentary: Verisk’s entrenched insurance data franchise, exceptional cash conversion, and high returns on invested capital support a strong fundamental assessment. Historical valuation compression provides additional support, while the unresolved AccuLynx transaction creates the principal risk deduction.
Q10-A2. Should You Buy Verisk? (Recommendation)
- Recommendation: Buy
- Commentary: Verisk offers a durable combination of recurring revenue, specialized insurance data advantages, high profitability, and shareholder cash returns at a valuation below its historical norms. Investors should nevertheless recognize that acquisition financing and the sustainability of cash-flow growth remain important constraints on near-term upside.
Q10-A3. Investment Thesis in One Line
- Verisk combines a durable insurance data moat, exceptional cash conversion, and a historically discounted valuation, although the unresolved AccuLynx acquisition threatens financial flexibility and capital-allocation returns.
Q10-A4. Verisk’s Price Trend & Key Drivers
- Stock Price Trend Over the Past 12 Months: Moderately Declining With a Recent Recovery 📉↗️ — The stock declined approximately 5.6% over the trailing 52 weeks through October 30, 2026, while trading between $155.94 and $227.16. The latest close of $196.30 was above the 50-day and 200-day moving averages.
- July 29, 2026 Q2 2026 Earnings and McKenzie Intelligence Services Acquisition
- Description: Verisk reported continued organic growth, strong FCF generation, and expanded catastrophe intelligence capabilities. The announcement also reinforced the importance of future acquisition integration.
- Stock Price Reaction: Mixed Trading 📈↘️ — The earnings period occurred during a broader volatile summer trading range; a sufficiently isolated immediate announcement-day direction was not established.
- October 23, 2026 Delaware Supreme Court Affirms AccuLynx Ruling
- Description: The court affirmed the judgment requiring Verisk to continue pursuing the transaction, creating uncertainty over potential acquisition financing and integration economics.
- Stock Price Reaction: Decline 📉 — Shares closed at $195.88 on October 23, down approximately 3.7% from the preceding session. The observed decline coincided with the ruling, although its isolated causal contribution cannot be determined.
- October 28, 2026 Insurance Intelligence Expansion Across AI Platforms
- Description: Verisk announced new distribution initiatives involving major AI platforms, offering a possible path to expand usage of proprietary insurance intelligence.
- Stock Price Reaction: Recovery 📈 — Shares rose from $187.73 on October 27 to $189.80 on October 28 and $196.30 by October 30. The recovery occurred around the announcement period, without establishing that the product news was its sole cause.
Q10-A5. Action Plan
- Current Price: $196.30
- Buy Zone: $175.00 ($170.00–$180.00)
- (1) Calculation of Fundamental Value: A conservative entry valuation emphasizes the company’s normalized cash generation and potential acquisition financing costs. A purchase around $170-$180 corresponds to approximately 17.9x-19.0x the latest TTM FCF per current share, offering a more attractive cash-flow yield than the current price.
- (2) Momentum Premium/Discount Application: The recent recovery does not yet justify a substantial momentum premium because the next earnings release and acquisition uncertainty can materially change expectations.
- (3) Conclusion: The $170.00-$180.00 range, with a midpoint of $175.00, balances cash-flow valuation support with the need for a discount against unresolved transaction risks.
- Price Target: $213.75
- Expected Return: +8.9% (vs. current price)
- 📍 Selected Valuation Metric: Forward normalized adjusted EPS multiplied by a justified earnings multiple — a 6-12-month valuation using estimated FY2027 earnings that captures recurring profitability and continued per-share growth.
- 🧮 Price Target Calculation Formula: FY2027 analyst-estimated normalized adjusted EPS $8.55 × target forward P/E 25.0x = $213.75
- ⚓ Valuation Basis and Key Assumptions: The FY2027 normalized adjusted EPS estimate of $8.55 is an independent analytical assumption, not management guidance or confirmed consensus. It assumes approximately 5%-6% organic revenue growth, modest operating leverage, and continued per-share benefits from capital allocation, starting from FY2026 adjusted EPS guidance of $7.45-$7.75. A 25.0x multiple reflects the company’s durable moat and high returns but remains below several historical premium valuations because insurance growth is moderate and acquisition financing remains uncertain. The historical cash-flow multiple comparison suggests more relative upside than the forward earnings target; the target is more restrained because it recognizes potential financing costs, weaker GAAP earnings conversion, and a lower sustainable valuation premium. Changes in acquisition funding or normalized EPS could materially affect the result.
- Conditions and timing for reaching price target: Over the next 6-12 months, the company needs to demonstrate sustained organic growth and cash generation, beginning with the November 5, 2026 earnings release. Greater clarity on AccuLynx financing and integration economics would also support a more stable valuation.
- Stop Loss: $153.00 ($150.00–$156.00)
- Action trigger upon catalyst achievement:
- 1 Q3 2026 results confirm organic growth and operating resilience
- Description: Maintain exposure if revenue growth, margins, and forward cash-flow assumptions remain intact. Additional buying should depend on the prevailing valuation and entry range. 👉 Maintain Holdings (Hold)
- 2 AI product integrations deliver measurable incremental recurring revenue
- Description: Reassess growth assumptions if adoption and monetization become financially material rather than merely demonstrating technical distribution. 👉 Consider Adding (Buy)
- 3 AccuLynx uncertainty is resolved with manageable financial terms
- Description: Reevaluate leverage, integration spending, and expected cash returns before treating the resolution as a positive catalyst. 👉 Maintain Holdings (Hold)
- 1 Q3 2026 results confirm organic growth and operating resilience
- Action trigger upon risk realization:
- 1 Acquisition financing materially raises expected leverage
- Description: Reduce exposure if the financing plan undermines free cash-flow resilience or requires a substantial reduction in shareholder distributions. 👉 Reduce Holdings (Sell)
- 2 Organic growth deteriorates across underwriting and claims
- Description: Reassess the moat and earnings assumptions if weakness persists beyond an isolated reporting period. 👉 Reduce Holdings (Sell)
- 3 The stock falls through the predefined risk-control range
- Description: Review whether the decline reflects fundamental deterioration, acquisition developments, or broad market volatility and enforce the predetermined risk limit where appropriate. 👉 Reduce Holdings (Sell)
- 1 Acquisition financing materially raises expected leverage
- Customized Strategy Guide by Investment Preference:
- Defensive Investors: Favor the lower portion of the buy zone and require clearer evidence of acquisition financing discipline before establishing a full position.
- Neutral Investors: Build positions gradually within the defined entry range, emphasizing quarterly cash generation and organic revenue growth.
- Aggressive Investors: Consider a smaller initial allocation ahead of earnings, adding only when results and acquisition developments support the underlying valuation assumptions.
🕵️♂️ Deep Dive Analysis
Q1: Is Verisk’s $2.35B AccuLynx Acquisition Its Biggest Threat to Shareholder Value?
- Analysis: Verisk’s existing business generates substantial recurring cash flow, but the potential acquisition represents a major capital commitment. The Delaware Supreme Court ruling limits management’s ability to abandon the agreement, while FTC approval and remaining closing conditions still determine whether the transaction proceeds. If completed, financing costs and integration expenses could meaningfully change repurchase capacity and the economics of future cash-flow growth. The core analytical question is whether the acquired business can produce returns that justify the additional capital employed.
- Judgment: Negative — The dispute creates a material and unusually difficult-to-control capital-allocation risk, even though the underlying insurance analytics franchise remains financially strong.
Q2: Can Verisk’s 24x Forward P/E Be Justified by Its Insurance Data Moat?
- Analysis: A forward P/E of approximately 24.0x is close to the selected comparable information-services peer average. Verisk’s high ROIC, recurring revenue, and strong cash conversion support a premium to ordinary service businesses. However, mid-single-digit organic growth and potential acquisition financing limit the multiple investors should rationally pay. Historical valuation compression provides support, but a return to previous peak multiples is not essential to the investment case.
- Judgment: Fairly Valued to Moderately Undervalued — Current pricing appears supportable by normalized earnings and cash-flow economics, although upside depends on consistent execution rather than multiple expansion alone.
Q3: Can Verisk Sustain Organic Revenue Growth Above 5% Without Major Acquisitions?
- Analysis: Verisk’s FY2025 organic growth excluding acquisitions and dispositions was approximately 6.9%, while Q2 2026 organic constant-currency growth reached 5.8%. New catastrophe models, underwriting datasets, and workflow expansion offer opportunities for incremental customer spending. Nevertheless, the industry’s maturity means that sustained acceleration would require deeper penetration, higher pricing, or new product adoption rather than simple market expansion.
- Judgment: Positive — Mid-single-digit organic growth appears sustainable under a reasonable operating scenario, but sustained double-digit expansion is not supported by the current evidence.
Q4: Does Verisk’s 31.7% ROIC Demonstrate a Durable Competitive Advantage?
- Analysis: Verisk’s ROIC materially exceeds its estimated cost of capital and compares favorably with major information-services companies. This performance reflects pricing power, reusable datasets, and relatively low physical capital requirements. Accounting invested capital can be affected by past acquisitions and repurchases, however, so the ROIC figure should be interpreted alongside cash returns and future incremental investment requirements.
- Judgment: Positive — The unusually large economic return spread strongly supports the existence of an enduring competitive advantage.
Q5: Could Generative AI Weaken Verisk’s Insurance Data Pricing Power?
- Analysis: Generative AI can automate reporting, workflow tasks, and some analytical processes, potentially reducing the differentiation of generic software interfaces. Verisk’s proprietary historical datasets, industry-specific models, and existing insurer integrations are harder to replace. Partnerships with AI platforms may expand distribution, but they can also shift negotiating power toward technology intermediaries if proprietary content becomes less differentiated.
- Judgment: Neutral — AI is both a monetization opportunity and a competitive threat. The decisive factor is whether Verisk retains control over valuable insurance data and captures incremental economic value from distribution.
Q6: Why Has Verisk’s Free Cash Flow Grown Faster Than Its Revenue?
- Analysis: TTM revenue growth of approximately 5.0% contrasts with FCF growth above 20%, reflecting strong conversion, working-capital movements, and capital-spending discipline. FCF margin expanded to approximately 39.4%. Some improvement is operationally sustainable, but cash collection, vendor payments, and tax timing can affect individual reporting periods. Future cash-flow growth should therefore be evaluated over multiple quarters rather than extrapolated directly from one period.
- Judgment: Positive With Qualifications — Strong cash generation is a genuine financial advantage, but maintaining current conversion rates is more important than repeating an unusually favorable quarterly growth rate.
Q7: Are Verisk’s Share Repurchases Creating Value or Increasing Financial Risk?
- Analysis: Verisk has substantially reduced shares outstanding, enhancing per-share earnings and cash flow. However, aggressive repurchases alongside net debt of approximately $4.06B reduce financial flexibility. The proposed AccuLynx transaction highlights the opportunity cost of maintaining a large repurchase program when strategic capital requirements are uncertain. Repurchases create economic value only when their price and financing cost compare favorably with alternative uses of capital.
- Judgment: Mixed — Share retirement benefits continuing investors, but capital allocation should remain subordinate to adequate liquidity and acceptable incremental investment returns.
Q8: How Much Could the AccuLynx Transaction Change Verisk’s Balance Sheet?
- Analysis: The proposed purchase price of $2.35B is equivalent to approximately 58% of existing net debt and nearly twice the most recent TTM FCF. Funding terms have not been finalized. An all-debt-financed transaction would materially increase leverage, while partial funding with accumulated cash or reduced repurchases would change the impact. Acquisition-related earnings and EBITDA contributions could offset some of the increased financing burden, but these benefits should not be assumed without reliable integration economics.
- Judgment: Negative Until Clarified — The transaction could materially alter Verisk’s financial flexibility, and its ultimate economic impact depends on financing, approval, closing, and post-acquisition performance.
Q9: Can Verisk’s Underwriting Franchise Continue Outgrowing Its Claims Business?
- Analysis: Underwriting represented approximately 70.9% of FY2025 revenue and grew 7.7%, compared with 4.1% growth in claims. Demand for improved catastrophe modeling, property risk information, and specialized insurance pricing analytics supports this relative strength. Claims remains strategically valuable through repair estimation, fraud detection, and workflow integration, but its slower growth means consolidated performance is especially sensitive to underwriting trends.
- Judgment: Positive — Underwriting remains the principal growth engine, while claims provides diversification within the broader insurance workflow ecosystem.
Q10: What Would Invalidate Verisk’s Long-Term Quality Compounder Investment Case?
- Analysis: The investment case would weaken materially if organic growth slowed persistently, operating margins deteriorated, or cash-flow conversion failed to support expected reinvestment and financing commitments. Acquisition-related leverage could amplify these problems if integration economics disappoint. Conversely, stable mid-single-digit growth, strong renewals, disciplined borrowing, and consistently high returns on invested capital would support continued long-term compounding.
- Judgment: Conditionally Positive — Verisk remains a fundamentally attractive recurring-revenue business, but sustained cash-flow economics and acquisition discipline are essential to preserving shareholder value.